While Benda has its problems, it is hard to believe the share price continues to languish at these prices, especially because they are the owners of Gendicine, the first-ever approved and apparently effective gene therapy for cancer, among so many other positives.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.